Autoimmune
14
5
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (14)
Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.
Taper Or Abrupt Steroid Stop: TOASSTtrial
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Use of Stromal Vascular Fraction in Multiple Sclerosis
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus
7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis
The Human Microbiome in Immune-Mediated Diseases
Systemic Lupus Erythematosus
Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions
Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease
Effect of Green Tea on Treatment of Lupus